Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$53.22 - $123.09 $4.16 Million - $9.62 Million
-78,180 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $446,278 - $657,394
4,380 Added 5.93%
78,180 $9.09 Million
Q4 2021

Feb 16, 2022

BUY
$118.18 - $153.21 $5.06 Million - $6.56 Million
42,810 Added 138.14%
73,800 $11.1 Million
Q3 2021

Nov 12, 2021

BUY
$93.51 - $129.4 $2.9 Million - $4.01 Million
30,990 New
30,990 $3.7 Million
Q4 2020

Feb 17, 2021

SELL
$86.4 - $121.75 $11.4 Million - $16.1 Million
-131,850 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$95.43 - $116.09 $2.87 Million - $3.49 Million
30,065 Added 29.54%
131,850 $15 Million
Q2 2020

Aug 14, 2020

BUY
$60.05 - $98.92 $862,918 - $1.42 Million
14,370 Added 16.44%
101,785 $10.1 Million
Q1 2020

May 13, 2020

BUY
$47.37 - $90.04 $4.14 Million - $7.87 Million
87,415 New
87,415 $5.63 Million
Q4 2019

Feb 14, 2020

SELL
$53.13 - $71.19 $3.19 Million - $4.27 Million
-59,971 Closed
0 $0
Q3 2019

Nov 15, 2019

SELL
$57.11 - $73.3 $4.35 Million - $5.58 Million
-76,170 Reduced 55.95%
59,971 $3.54 Million
Q2 2019

Aug 13, 2019

SELL
$54.41 - $71.7 $866,479 - $1.14 Million
-15,925 Reduced 10.47%
136,141 $8.78 Million
Q1 2019

May 14, 2019

SELL
$32.25 - $73.56 $4.13 Million - $9.42 Million
-128,114 Reduced 45.73%
152,066 $9.66 Million
Q4 2018

Feb 12, 2019

SELL
$28.45 - $40.65 $2.04 Million - $2.91 Million
-71,670 Reduced 20.37%
280,180 $10.6 Million
Q3 2018

Nov 15, 2018

SELL
$21.39 - $51.17 $2.21 Million - $5.29 Million
-103,320 Reduced 22.7%
351,850 $15.1 Million
Q2 2018

Aug 15, 2018

BUY
$4.9 - $23.64 $2.23 Million - $10.8 Million
455,170 New
455,170 $10 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.98B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.